Knee Arthroplasty Registry a. Function and Survival Stratified by BMI b. Return of Quadriceps Strength After Primary TKA
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 7,793
- 试验地点
- 1
- 主要终点
- Knee Society Score
研究概览
简要总结
Objective
Describe the clinical and demographic characteristics of patients who undergo knee arthroplasty and document post operative outcomes.
Examine the relationship between processes of care, hospital and surgeon associated outcomes.
Provide expanded data to characterize existing and evolving practice patterns, delivery of care, and resource utilization in the management of knee arthroplasty patients.
Analyze and design ancillary studies to address unanswered questions.
Disseminate findings through publication in peer-reviewed scientific journals.
详细描述
Population: All male and non-pregnant females undergoing knee arthroplasty.
Study Design: Prospective, consecutive series on an unlimited number of patients.
Data Collection
Clinic Data:
Patient Demographics- age, weight, height, gender, affected side, co-morbidities, current medications, and contact information Knee Society Score SF-12 Evaluation of radiographs- AP, ML, and merchant view Preop lab results
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 21 Years 至 93 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient is a male or non-pregnant female over the age of
- •Patient requires a knee arthroplasty, revision knee arthroplasty, or unicondylar knee arthroplasty
- •Patient has signed and dated an IRB approved consent form.
- •Patient is able and willing to participate in the study according to the protocol for the full length of expected term of follow-up, and to follow their physician's directions.
- •Patient has failed to respond to conservative treatment modalities.
排除标准
- •Patient's bone stock is compromised by disease or infection, which cannot provide adequate support and/or fixation to the prosthesis.
- •Patient is a prisoner.
结局指标
主要结局
Knee Society Score
时间窗: 2 weeks, 6 weeks, 3 months, 6 months, 1, 2, 5, 10 years
次要结局
未报告次要终点
研究者
R. David Heekin, MD
R. David Heekin, M.D.
Heekin Orthopedic Research Institute
